SCHEMBL6525264

SCHEMBL6525264

C=CCOP(=O)(CP(=O)(O)O)OC

nearest known ligand 0.33

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.33
MMP2 P08253 1/20 0.33
THRB P10828 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
FNTA P49354 1/20 0.32
FNTB P49356 1/20 0.32
LPAR2 Q9HBW0 1/20 0.32
LPAR3 Q9UBY5 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7623221 0.78
SCHEMBL27769875 0.78 TSHR (0.41)
SCHEMBL7647258 0.76 KDM4E (0.50) KDM4EMMP2THRBMAPK1HSD17B10
SCHEMBL11325232 0.76
SCHEMBL26605993 0.75 TSHR (0.48) KDM4EMMP2THRBMAPK1HSD17B10
SCHEMBL2358290 0.75 FNTA (0.46) KDM4EMMP2THRBMAPK1HSD17B10
SCHEMBL4957358 0.75
SCHEMBL17331087 0.74 ALDH1A1 (0.37) HSD17B10
SCHEMBL2358289 0.74 LPAR2 (0.31) LPAR2LPAR3
SCHEMBL9055105 0.74 LPAR2 (0.34) FNTAFNTBLPAR2LPAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6909010-B2 Facile synthesis of symmetric esters of alkylenebisphosphonic acids LOYOLA UNIVERSITY OF CHICAGO (US) 2005-06-21 US disclosed
US-20030060648-A1 Facile synthesis of symmetric esters of alkylenebisphosphonic acids LOYOLA UNIVERSITY OF CHICAGO 2003-03-27 US disclosed
WO-2002085918-A1 A FACILE SYNTHESIS OF SYMMETRIC ESTERS OF ALKYLENEBISPHOSPHONIC ACIDS LOYOLA UNIVERSITY OF CHICAGO (US) 2002-10-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030060648-A1 Facile synthesis of symmetric esters of alkylenebisphosphonic acids PHOSPHO1, ADH1C, PAICS KDM4E 3463/4885MMP2 3502/4885THRB 815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.